Literature DB >> 2816304

Rapid increase of prostaglandin F2-alpha in neurons after subarachnoid hemorrhage in rats: an immunohistochemical study.

H Ogawa1, N F Kassell, T Sasaki, T Nakagomi, K Hongo, T Tsukahara.   

Abstract

The effects of subarachnoid hemorrhage (SAH) with various degrees of increase in intracranial pressure (ICP) on the staining of prostaglandin F2-alpha (PG F2alpha) were studied in rat brains. SAH was produced in 18 rats by injection of 0.18-0.20 ml of autologous arterial blood/100 g body weight into the cisterna magna. By changing the speed of injection, the ICP was transiently increased by 346 +/- 68 (mean +/- S.D.) mm Hg in eight rats (including three pretreated with indomethacin), by 200 +/- 42 mm Hg in five rats, and by 6 +/- 4 mm Hg in the other five. Three rats injected with the same volume of mock cerebrospinal fluid (CSF) with ICP increased by 217 +/- 67 mm Hg and five normal rats without injection served as controls. All animals were decapitated 15 min after injection. The cryosections were stained for PG F2 alpha using an indirect immunofluorescence method. Positive staining for PG F2 alpha was noted only in pial vessels in all normal and mock-CSF-injected rats. In SAH rats with ICP increased by 6 +/- 4 mm Hg, there was a positive reaction in hippocampal neurons and Purkinje cells as well as blood vessels. SAH rats with higher ICP showed stronger PG F2 alpha staining in the above areas, as well as in cerebellar granule cells. All rats pretreated with indomethacin showed a smaller increase in staining. The above results indicate that subarachnoid blood clots per se produce a rapid increase of PG F2 alpha in neurons and blood vessels of both cerebrum and cerebellum, and that this increase is augmented by intracranial hypertension.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2816304     DOI: 10.1007/BF00691289

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  28 in total

1.  Measurement of prostaglandin F2alpha levels in human cerebrospinal fluid in normal and pathological conditions.

Authors:  L S Wolfe; O A Mamer
Journal:  Prostaglandins       Date:  1975-02

2.  Differential intracranial pressure in patients with unilateral mass lesions.

Authors:  D D Weaver; H R Winn; J A Jane
Journal:  J Neurosurg       Date:  1982-05       Impact factor: 5.115

3.  Barrier disruption in the major cerebral arteries after experimental subarachnoid hemorrhage in spontaneously hypertensive and normotensive rats.

Authors:  M Zuccarello; N F Kassell; T Sasaki; S Fujiwara; T Nakagomi; R M Lehman
Journal:  Neurosurgery       Date:  1987-10       Impact factor: 4.654

4.  Intracranial pressure changes following aneurysm rupture. Part 1: clinical and angiographic correlations.

Authors:  B Voldby; E M Enevoldsen
Journal:  J Neurosurg       Date:  1982-02       Impact factor: 5.115

5.  Leukotrienes in the rat central nervous system.

Authors:  J A Lindgren; T Hökfelt; S E Dahlén; C Patrono; B Samuelsson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

6.  Prostaglandin F2 alpha levels in human cerebrospinal fluid in normal and pathological conditions.

Authors:  D Egg; M Herold; E Rumpl; R Günther
Journal:  J Neurol       Date:  1980       Impact factor: 4.849

7.  Intracranial pressure changes following aneurysm rupture. Part 3: Recurrent hemorrhage.

Authors:  B Voldby; E M Enevoldsen
Journal:  J Neurosurg       Date:  1982-06       Impact factor: 5.115

8.  Regional and species differences in endogenous prostaglandin biosynthesis by brain homogenates.

Authors:  M S Abdel-Halim; E Anggård
Journal:  Prostaglandins       Date:  1979-03

9.  Pathogenetic role of no-reflow phenomenon in experimental subarachnoid hemorrhage in dogs.

Authors:  T Asano; K Sano
Journal:  J Neurosurg       Date:  1977-04       Impact factor: 5.115

10.  Prostaglandin profiles in nervous tissue and blood vessels of the brain of various animals.

Authors:  M S Abdel-Halim; I Lundén; G Cseh; E Anggård
Journal:  Prostaglandins       Date:  1980-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.